Science
Mechanism of Action
This ingredient is hypothesized to exert its effects by leveraging the established mechanisms of its constituent parts. The retinoyl moiety is expected to modulate epithelial cell differentiation, diminish comedone formation, and accelerate skin cell turnover by enhancing mitotic activity and the shedding of cornified cells. It may also stimulate collagen production and inhibit its breakdown. Concurrently, the tripeptide component is believed to engage in cell signaling within the skin, influencing vital processes such as extracellular matrix synthesis, pigmentation regulation, immune responses, and inflammation.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
The retinoyl component is known to exhibit poor solubility in water and is highly susceptible to degradation from light and oxygen. For optimal storage stability, formulations should maintain a pH of 5.0 or above, as retinoids are generally incompatible with acidic conditions.
Safety
Safety Profile
No specific safety assessments by CIR, SCCS, or FDA have been conducted for Retinoyl Tripeptide-35. However, the CIR has reviewed other tripeptides (e.g., Tripeptide-1) and retinol, concluding their safety under specific conditions, which may offer a partial reference for this hybrid ingredient.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Given the absence of specific clinical efficacy data and comprehensive safety assessments for Retinoyl Tripeptide-35, its overall rating remains 'insufficient-data,' necessitating further dedicated research for a definitive evaluation.
Related
Similar Ingredients
Finding similar ingredients…